Advanced HPV, dysplasia, and anal cancer screening in Seattle, Washington
Anal Cancer Screening and Prevention
Anal HPV is common, and precancerous changes often cause no symptoms. Dr. Kratz provides anal cancer screening, high-resolution anoscopy, biopsy, treatment of anal HSIL, and ongoing surveillance, all within one specialized program. Treatment of anal HSIL has been shown to significantly reduce progression to anal cancer in high-risk patients.
Most people carry HPV without ever knowing it.
Anal HPV and precancerous changes often cause no pain, bleeding, or other warning signs. That's why screening is based primarily on risk, not symptoms. In people at increased risk, screening can identify abnormal cells before they progress to cancer.
What We Screen and Treat
Four parts of one program, one surgeon overseeing all of it.
Anal Warts
Diagnosis and removal of anal warts caused by low-risk HPV, using minimally invasive techniques like chemical treatment, electrocautery, or excision.
HPV and Abnormal Cells
Evaluation and treatment of high-risk HPV and the precancerous cell changes it can cause, including anal intraepithelial neoplasia (AIN).
Anal Cancer Screening
A dedicated screening program for patients at higher risk of anal cancer, following the protocol established by the ANCHOR Study.
High-Resolution Anoscopy
The magnified, in-office exam used to find and treat abnormal tissue before it becomes cancer.
Evidence-based, not experimental
The ANCHOR Study, a landmark national trial, proved that treating high-grade anal dysplasia significantly reduces the risk of developing anal cancer. That finding changed how anal cancer prevention is practiced, and it's the standard this program follows.
Screening, biopsy, and treatment happen in one office, without routing patients through a separate specialist for each step.
Screening, biopsy, and treatment happen in one office, without routing patients through a separate specialist for each step.
Who should be screened
Screening is recommended or should be considered for people at increased risk, including:
Men who have sex with men and transgender women with HIV, beginning at age 35
Other people living with HIV, beginning at age 45
Men who have sex with men and transgender women without HIV, generally beginning at age 45
People with a history of vulvar precancer or cancer
Solid-organ transplant recipients
Selected patients age 45+ with cervical/vaginal HSIL or cancer, perianal warts, persistent high-risk HPV, or other significant risk factors
Not sure whether you should be screened? We can review your individual risk and determine whether screening is appropriate.
Specialized Anal HPV Care, All in One Place
One specialized program.
Screening, HRA, targeted biopsy, treatment, and surveillance are coordinated through the same practice.
Continuity of care.
Your care is overseen by Dr. Kratz rather than being passed between unrelated clinics for each stage.
Treatment when abnormal cells are found.
The goal isn't simply to identify disease. It's to manage it before it progresses.
Designed for privacy and discretion.
A judgment-free environment experienced in caring for LGBTQ+ patients and others at increased risk for anal HPV.
What it costs
Evaluation and treatment for anal HPV, dysplasia, and abnormal cells are medically necessary services and frequently covered by insurance. Our billing team reviews your benefits and gives you pricing before your visit.
Common questions
Do I need a referral?
Is HPV the same thing as anal cancer?
Will I need surgery?
Is this covered by insurance?
Is my visit private?
Early detection is the difference.
Call or text for a private consultation and a clear plan.